Literature DB >> 3518215

Determination of IgM and IgG antibodies to Toxoplasma using the IFA test, ELISA, and Dot-ELISA procedures.

M G Pappas, M N Lunde, R Hajkowski, J McMahon.   

Abstract

The dot enzyme-linked immunosorbent assay (Dot-ELISA) and the enzyme-linked immunosorbent assay (ELISA) were compared with the immunofluorescent antibody test (IFA) for detection of IgM- and IgG-specific antibodies to human toxoplasmosis. Reciprocal titers were determined in all three assays using sera from 56 patients with suspected toxoplasmosis or with symptoms and diseases requiring exclusion of toxoplasmosis and control sera from 56 healthy persons. Using the Dot-ELISA, six patient sera (10.7%) were positive at titers of greater than equal to 1024 for IgM antibodies (titer range 1024-16 384) and 47 sera (84%) were positive for IgG antibodies (titer range 16-262 144) at a titer of greater than or equal to 16. One control serum was reactive for IgM (titer 1024) and 10 control sera (18%) were positive for IgG in the Dot-ELISA. In the ELISA, at titers of greater than or equal to 128, five sera (9%) were reactive for IgM (titer range 128-512) and 52 sera (92.8%) were reactive for IgG (titer range 32-8192) at a titer of greater than or equal to 32; no control sera gave positive reactions for IgM while 10 sera (18%) were positive for IgG in the ELISA. Using the IFA test at reciprocal titers of greater than or equal to 16, four sera (7.1%) were positive for IgM (titer range 32-512), and 51 sera (91%) were positive for IgG (titer range 16-8192). None was reactive for IgM, and eight sera (14%) were positive for IgG (titer range 32-128) in the IFA test. The Dot-ELISA correlated well with the IFA test (correlation coefficient = 0.895) and the ELISA correlated slightly higher with the IFA test (correlation coefficient = 0.910) for detection of IgG antibodies to Toxoplasma gondii.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518215     DOI: 10.1016/0304-4017(86)90090-7

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  8 in total

1.  Diagnosis of bovine sarcocystosis by immunoflourescent antibody technique.

Authors:  Dasmabai Banothu; Udayakumar Manchukonda; V C Rayulu
Journal:  J Parasit Dis       Date:  2017-02-28

2.  Recombinant Leishmania Hsp90 and Hsp70 are recognized by sera from visceral leishmaniasis patients but not Chagas' disease patients.

Authors:  C R de Andrade; L V Kirchhoff; J E Donelson; K Otsu
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

3.  Rapid Detection of Toxoplasma gondii Antigen in Experimentally Infected Mice by Dot- ELISA.

Authors:  S Jafar Pour Azami; H Keshavarz; M Rezaian; M Mohebali; S Shojaee
Journal:  Iran J Parasitol       Date:  2011-03       Impact factor: 1.012

Review 4.  Diagnosis of toxoplasmosis and typing of Toxoplasma gondii.

Authors:  Quan Liu; Ze-Dong Wang; Si-Yang Huang; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2015-05-28       Impact factor: 3.876

5.  Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections.

Authors:  Aref Teimouri; Mohammad Hossein Modarressi; Saeedeh Shojaee; Mehdi Mohebali; Mostafa Rezaian; Hossein Keshavarz
Journal:  Infect Drug Resist       Date:  2019-08-27       Impact factor: 4.003

Review 6.  Review on the Current Trends of Toxoplasmosis Serodiagnosis in Humans.

Authors:  Rochelle Haidee D Ybañez; Adrian P Ybañez; Yoshifumi Nishikawa
Journal:  Front Cell Infect Microbiol       Date:  2020-05-08       Impact factor: 5.293

7.  Serological survey of toxoplasmosis in a district in Tamil Nadu: hospital-based study.

Authors:  G Sucilathangam; N Palaniappan; C Sreekumar; T Anna
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

8.  Beneficial Effects of Capparis Spinosa Honey on the Immune Response of Rats Infected with Toxoplasma Gundii.

Authors:  Ahmed Gaffer Hegazi; Fayez Mohammed Al Guthami; Ahmed Faiz Al Gethami; Hassan Ali El Fadaly
Journal:  J Pharmacopuncture       Date:  2017-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.